Cambridge biotech start-up; benchtop biosensor platform for cell-line monitoring.
More about Abselion
Abselion is a life sciences technology company based in Cambridge, UK, founded in 2018 as a spin-out from the University of Cambridge. The company specializes in measurement tools that enhance biomolecule quantification for biologics development, gene therapy, and synthetic biology workflows. Abselion combines engineering solutions with purpose-built assays and intuitive software to provide reliable and fast results from crude samples. The flagship Amperia™ platform utilizes Redox Electrochemical Detection (RED) technology for the quantification of antibodies, adeno-associated viruses (AAVs), tagged proteins, and other biomolecules. Key offerings include the automated Amperia instrument for protein quantification, ready-to-use assay kits for specific targets, precision detection sensors, and validated consumables and reagents. These tools facilitate efficient protein analytics and streamline workflows from discovery to production, supporting researchers and developers in the life sciences sector.
Live roles
Alert me when Abselion posts a new role Email me when this changes
Similar Cambridge companies
Full directory →- Kymab / Sanofi Cambridge 47 live
- AstraZeneca 13 live
Cambridge-headquartered global pharma; major presence at the Cambridge Biomedical Campus. Heavy AI/ML hiring across genetics, drug discovery and biologics engineering.
- GSK 6 live
Global pharma; Stevenage R&D campus is the company's largest UK research site. Active in AI/ML for drug discovery, translational data, and oncology pharmacology.
- Illumina 6 live
Cambridge-based (Chesterford Research Park) arm of Illumina developing DNA sequencing instruments and technology.
- Tailor Bio 4 live
- Healx 2 live
Cambridge AI-for-rare-disease scale-up; ML platform for drug repurposing and combination discovery. Strong ML/data hiring track record.